Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-13

Clinical Trial Update: Individualized Neuromodulation for Anhedonic Depression [NA]

View source ↗

Summary

A clinical trial evaluating individualized neuromodulation for anhedonic depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Not specified

Snippet

Sponsor: University of California, San Diego | Conditions: MDD, Anhedonia | NA | Status: COMPLETED